Pancreatic Cancer Research

ResearcherGastroenterology Hospital "Saverio de Bellis"Active in the last 2 years

Raffaele Armentano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1661-5504; OpenAlex author ID A5103204305. Sources: ClinicalTrials.gov.

Their work

Papers
2 (first author 0, last author 2)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper, 1 trial

Papers 2

  1. p38α Signaling Is Associated with Pancreatic Ductal Adenocarcinoma Progression and Represents a Potential Therapeutic Vulnerability. Last author DOI 10.3390/ijms27198550↗
  2. Claudin 18.2: An attractive marker in pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ol.2025.14886↗

Trials 1

  1. Predictive Biomarkers for Early Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) Principal investigator NCT07709052↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anna Maria Valentini · 2 shared papers, 2025–2026 · strength 0.52
  2. Ilaria Grassi · 2 shared papers, 2025–2026 · strength 0.52
  3. Cristiano Simone · 1 shared paper, 2026 · strength 0.28
  4. Graziana Arborea · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.